Wisdom Pharmaceuticals: Application for issuance of shares to specific entities approved by the Shenzhen Stock Exchange.

Rui Zhi Pharmaceutical announced that on July 1, 2026, the company received a notice from the Shenzhen Stock Exchange Listing Review Center stating that its application to issue shares to specific targets has been approved. The center believes that the company meets the conditions for issuance and listing as well as information disclosure requirements. The Shenzhen Stock Exchange will report to the China Securities Regulatory Commission for registration procedures. The implementation of this matter still requires approval from the CSRC, and there is uncertainty regarding whether it will be approved and the timeline. The company will disclose any progress in a timely manner.